Role of T Cells in Viral Infections (Including SARS-CoV-2)

 

Selected References

  1. Kusnadi A, Ramírez-Suástegui C, Fajardo V, Chee SJ, Meckiff BJ, Simon H, Pelosi E, Seumois G, Ay F, Vijayanand P, Ottensmeier CH. Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+T cells. Sci Immunol. 2021 Jan 21;6(55):eabe4782. doi: 10.1126/sciimmunol.abe4782. PMID: 33478949.
  2. Meckiff BJ, Ramírez-Suástegui C, Fajardo V, Chee SJ, Kusnadi A, Simon H, Eschweiler S, Grifoni A, Pelosi E, Weiskopf D, Sette A, Ay F, Seumois G, Ottensmeier CH, Vijayanand P. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+T Cells in COVID-19. Cell. 2020 Nov 25;183(5):1340-1353.e16. doi: 10.1016/j.cell.2020.10.001. Epub 2020 Oct 5. PMID: 33096020; PMCID: PMC7534589.
  3. Patil VS, Madrigal A, Schmiedel BJ, Clarke J, O’Rourke P, de Silva AD, Harris E, Peters B, Seumois G, Weiskopf D, Sette A, Vijayanand P. Precursors of human CD4+cytotoxic T lymphocytes identified by single-cell transcriptome analysis. Sci Immunol. 2018 Jan 19;3(19):eaan8664. doi: 10.1126/sciimmunol.aan8664. PMID: 29352091; PMCID: PMC5931334.

 

Grants

NIH/NCI U01 CA260588-01, SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects

NIH/NIAID, U19AI14273-S1, Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses

NIH/NIAID, U19AI142742-03, Cooperative Centers on Human Immunology: Biology of human cytotoxic cd4 t cells (CD4-CTLs) in viral infections

About La Jolla Institute

The La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading toward its goal: life without disease. Visit lji.org for more information.

Share this Article:

LJI Professor Sujan Shresta, Ph.D., is a leader in dengue virus research and vaccine development
LJI and Synbal, Inc. scientists develop new tool for pandemic preparedness